» Articles » PMID: 19506720

The TNF-alpha System: Functional Aspects in Depression, Narcolepsy and Psychopharmacology

Overview
Date 2009 Jun 10
PMID 19506720
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Changes of the tumor necrosis factor-alpha (TNF-alpha) system have been shown to be involved in the development of psychiatric disorders and are additionally associated with changes in body weight as well as endocrine and metabolic changes in psychiatric patients. TNF-alpha might, for example, contribute to the pathogenesis of depression by an activation of the hypothalamo-pituitary-adrenocortical (HPA) axis, an activation of neuronal serotonin transporters and the stimulation of the indoleamine 2,3-dioxygenase which leads to tryptophan depletion. On the other hand, during an acute depressive episode, an elevated HPA axis activity may suppress TNF-alpha system activity, while after remission, when HPA axis activity has normalized the suppression of the TNF-alpha system has been shown not to be apparent any more.In narcoleptic patients, soluble TNF receptor (sTNF-R) p75 plasma levels have been shown to be elevated, suggesting a functional role of the TNF-alpha system in the development of this disorder.Additionally, psychotropic drugs influence the TNF-alpha system as well as the secretion and the effect of hormones which counteract or interact with the TNF-alpha system such as the intestinal hormone ghrelin. However, only preliminary studies with restricted sample sizes exist on these issues, and many open questions remain.

Citing Articles

Functional resting state connectivity is differentially associated with IL-6 and TNF-α in depression and in healthy controls.

Schmitz C, Sammer G, Neumann E, Blecker C, Grunder G, Adolphi H Sci Rep. 2025; 15(1):1769.

PMID: 39800770 PMC: 11725594. DOI: 10.1038/s41598-025-85514-0.


Inflammation biomarkers and neurobehavioral performance in rural adolescents.

Amdemicael B, Yang K, Chronister B, Mackey C, Tu X, Gahagan S Brain Behav Immun Health. 2024; 43:100912.

PMID: 39686922 PMC: 11648784. DOI: 10.1016/j.bbih.2024.100912.


Cognitive Impact of Neurotropic Pathogens: Investigating Molecular Mimicry through Computational Methods.

Buttiker P, Boukherissa A, Weissenberger S, Ptacek R, Anders M, Raboch J Cell Mol Neurobiol. 2024; 44(1):72.

PMID: 39467848 PMC: 11519248. DOI: 10.1007/s10571-024-01509-x.


Concomitant Treatment with Doxycycline and Rifampicin in Balb/c Mice Infected with 2308 Fails to Reduce Inflammation and Motor Disability.

Maldonado-Garcia J, Alvarez-Herrera S, Perez-Sanchez G, Becerril-Villanueva E, Pavon L, Tesoro-Cruz E Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794208 PMC: 11123987. DOI: 10.3390/ph17050638.


Chronic Stress-Induced Neuroinflammation: Relevance of Rodent Models to Human Disease.

White A, Elias E, Orozco A, Robinson S, Manners M Int J Mol Sci. 2024; 25(10).

PMID: 38791125 PMC: 11121038. DOI: 10.3390/ijms25105085.


References
1.
Harlan J, Chen Y, Gubbins E, Mueller R, Roch J, Walter K . Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol Psychiatry. 2005; 11(1):76-85. DOI: 10.1038/sj.mp.4001755. View

2.
Dauvilliers Y . [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy]. Rev Neurol (Paris). 2003; 159(11 Suppl):6S83-7. View

3.
Spies T, Morton C, Nedospasov S, Fiers W, Pious D, Strominger J . Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1986; 83(22):8699-702. PMC: 386998. DOI: 10.1073/pnas.83.22.8699. View

4.
Maes M, Song C, Lin A, Bonaccorso S, Kenis G, De Jongh R . Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 1999; 20(4):370-9. DOI: 10.1016/S0893-133X(98)00088-8. View

5.
Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K . Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology. 2004; 30(1):106-10. DOI: 10.1016/j.psyneuen.2004.05.008. View